|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.01 USD | +0.34% |
|
-6.94% | +39.06% |
| 30/01 | Leerink Partners Adjusts Moderna Price Target to $17 From $18, Maintains Underperform Rating | MT |
| 30/01 | Mib Outperforms Europe Ahead of S&P, Campari Leads Gains | AN |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 51.87 | 51.87 | 48.71 |
| Spread/Res. | -20.94% | -20.94% | -15.81% |
| Spread/Supp. | +4.19% | +21.19% | +21.33% |
| Support | 39.36 | 33.84 | 33.8 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- MRNA Stock
- Charts Moderna, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition